IBCA Stock UPDATES Intervest Bancshares (IBCA) 9.68 10/21/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Intervest Bancshares (IBCA) 9.68 $IBCA

Intervest Bancshares Corporation Reports 2014 Third Quarter Earnings Increase by 62% to $4.2 Million or $0.19 Per Share
Business Wire - Thu Oct 16, 7:00AM CDT
Intervest Bancshares Corporation (IBC) (NASDAQ-GS:IBCA), parent company of Intervest National Bank (INB), today announced that its net earnings available to common stockholders for the third quarter of 2014 (Q3-14) increased 62% to $4.2 million, or $0.19 per share, from $2.6 million, or $0.12 per share, for the third quarter of 2013 (Q3-13). For the first nine months of 2014 (9mths-14), net earnings available to common stockholders increased 49% to $13.8 million, or $0.62 per share, from $9.2 million, or $0.42 per share, for the same period of 2013 (9mths-13).
IBCA: 9.68 (+0.02)

Shares of IBCA Up 23.0% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Oct 15, 5:30PM CDT
SmarTrend identified an Uptrend for Intervest Bancshares (NASDAQ:IBCA) on December 30th, 2013 at $7.78. In approximately 10 months, Intervest Bancshares has returned 22.96% as of today's recent price of $9.56.
IBCA: 9.68 (+0.02)

Intervest Bancshares Up 23.6% Since SmarTrend Uptrend Call (IBCA)
Comtex SmarTrend(R) - Wed Oct 08, 11:04AM CDT
SmarTrend identified an Uptrend for Intervest Bancshares (NASDAQ:IBCA) on December 30th, 2013 at $7.78. In approximately 9 months, Intervest Bancshares has returned 23.60% as of today's recent price of $9.61.
IBCA: 9.68 (+0.02)

GRA, IBCA Expected To Be Up Before Next Earnings Releases
M2 - Wed Oct 08, 3:25AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released in the coming weeks and determining how the stocks have performed Before their last 12 quarterly, 6 quarterly and December earnings reports. W R Grace and Co (NYSE:GRA), Intervest Bancshares Corp (NASDAQ:IBCA) are all expected to be Up Before their earnings are released. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go Up Before earnings are released Wednesday:
GRA: 89.97 (+2.60), IBCA: 9.68 (+0.02)

Intervest Bancshares Has Returned 22.8% Since SmarTrend Recommendation (IBCA)
Comtex SmarTrend(R) - Wed Oct 01, 9:44AM CDT
SmarTrend identified an Uptrend for Intervest Bancshares (NASDAQ:IBCA) on December 30th, 2013 at $7.78. In approximately 9 months, Intervest Bancshares has returned 22.83% as of today's recent price of $9.55.
IBCA: 9.68 (+0.02)

Intervest Bancshares Shares Up 22.8% Since SmarTrend's Buy Recommendation (IBCA)
Comtex SmarTrend(R) - Wed Sep 24, 9:15AM CDT
SmarTrend identified an Uptrend for Intervest Bancshares (NASDAQ:IBCA) on December 30th, 2013 at $7.78. In approximately 9 months, Intervest Bancshares has returned 22.83% as of today's recent price of $9.55.
IBCA: 9.68 (+0.02)

ACHN, IBIO, CRAY, IBCA, QLTY, PIY Are Seasonally Ripe To Go Down In the Next Five Weeks
M2 - Tue Sep 16, 6:08AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Achillion Pharmaceuticals Inc (NASDAQ:ACHN), Ibio Inc (NYSE:IBIO), Cray Inc (NASDAQ:CRAY), Intervest Bancshares Corp (NASDAQ:IBCA), Quality Distribution Inc (NASDAQ:QLTY), Preferredplus Trust Series Czn 1 (NYSE IY) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
PIY: 25.94 (+0.38), QLTY: 12.30 (+0.55), ACHN: 11.43 (+0.44), IBIO: 1.74 (-0.44), IBCA: 9.68 (+0.02), CRAY: 28.85 (+0.70)

23.3% Return Seen to Date on SmarTrend Intervest Bancshares Call (IBCA)
Comtex SmarTrend(R) - Tue Sep 09, 11:01AM CDT
SmarTrend identified an Uptrend for Intervest Bancshares (NASDAQ:IBCA) on December 30th, 2013 at $7.78. In approximately 8 months, Intervest Bancshares has returned 23.34% as of today's recent price of $9.59.
IBCA: 9.68 (+0.02)

Intervest Bancshares Corporation Announces Repurchase of Outstanding TARP Warrant
Business Wire - Wed Sep 03, 10:52AM CDT
Intervest Bancshares Corporation (the "Company" (Nasdaq:IBCA), the holding company for Intervest National Bank, announced today that it has repurchased the warrant that had been issued to the U.S. Department of the Treasury in connection with the Company's participation in the TARP Capital Purchase Program. The Company paid Treasury $2,892,066 to repurchase the warrant, which has been cancelled. The Company had originally issued the warrant, which permitted Treasury to purchase up to 691,882 shares of the Company's common stock at an exercise price of $5.42 per share, on December 23, 2008. The Company repurchased all of the shares of TARP preferred stock in June and August of 2013. With the repurchase of the warrant, there are no other investments from the Company's participation in TARP that remain outstanding.
IBCA: 9.68 (+0.02)

INVESTOR ALERT - Intervest Bancshares Corp.: The Law Offices of Vincent Wong Investigates the Sale of Intervest Bancshares Corp. to Bank of the Ozarks, Inc. - IBCA
PR Newswire - Mon Aug 18, 4:14PM CDT
The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of Intervest Bancshares Corporation (NasdaqGS: IBCA) ("Intervest" in connection with the sale of the Company to Bank of the Ozarks, Inc. (NasdaqGS: OZRK).
IBCA: 9.68 (+0.02), OZRK: 32.83 (+0.75)

Lifshitz & Miller Law Firm Announces Investigation of Endocyte, Inc., EVOQ Properties Inc., Fortegra Financial Corporation, Intervest Bancshares Corporation and L-3 Communications Holdings, Inc.
PR Newswire - Mon Aug 18, 12:52PM CDT
Endocyte, Inc.
ECYT: 5.58 (-0.03), FRF: 9.82 (+0.02), IBCA: 9.68 (+0.02), LLL: 110.15 (+0.60)

INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation of Intervest Bancshares Corp. and Its Board of Directors In Connection With the Sale of the Company to Bank of the Ozarks, Inc. -- IBCA
Business Wire - Thu Aug 14, 1:27PM CDT
Levi & Korsinsky is investigating the Board of Directors of Intervest Bancshares Corporation ("Intervest" or "the Company" (NasdaqGS:IBCA) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Bank of the Ozarks, Inc. (NasdaqGS:OZRK).
IBCA: 9.68 (+0.02), OZRK: 32.83 (+0.75)

INTERVEST BANCSHARES SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Merger with Bank of the Ozarks
Business Wire - Thu Aug 14, 11:38AM CDT
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Intervest Bancshares Corp. ("Intervest" (NasdaqGS: IBCA) concerning the merger with Bank of the Ozarks, Inc. Under the terms of the definitive agreement, valued at approximately $228.5 million, Intervest shareholders will receive common shares of Bank of the Ozarks stock pursuant to the ten day average closing stock price as of the fifth business day prior to the closing date, with a minimum and maximum price of $23.95 and $39.91.
IBCA: 9.68 (+0.02), OZRK: 32.83 (+0.75)

SHAREHOLDER ALERT: Brower Piven Announces The Investigation Of Intervest Bancshares Corporation In Connection With The Proposed Sale Of The Company To Bank of the Ozarks, Inc.
Business Wire - Tue Aug 12, 5:10PM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Intervest Bancshares Corporation ("Intervest" or the "Company" (NASDAQ: IBCA) relating to the proposed buyout of the Company by Bank of the Ozarks, Inc. ("Ozarks" .
IBCA: 9.68 (+0.02), OZRK: 32.83 (+0.75)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Net Zero Efforts to Cost Europe €60B Annually by 2050

Updated Category News Views 91

Hefty Prices Loom Over Net Zero Commitments Well, strap in for a wallet buster, folks. Europe's largest players are staring down the barrel of a colossal €60 billion annual bill to clean up their carbon mess by 2050. That's the ticker in Senken's latest report, 'Pace of Change 2026.' Talks like these remind me there's no such thing as a free lunch, especially when...

Continue Reading
DemandTec Leads the Pack in Retail Pricing Arena

Updated Category News Views 26

DemandTec's Climb to Retail Pricing Stardom The news hitting the streets is that DemandTec's carved out a top spot in QKS Group's SPARK Matrix™ for Intelligent Retail Pricing & Promotion Optimization for 2026. In an industry filled with slick operators and gimmicks, it takes some real chops to stand out. They've clinched this position by rolling out a platform that ties...

Continue Reading
Roche Delivers Endotrophin Assay to Nordic Bioscience Lab

Updated Category News Views 43

Roche Opens New Frontier in Diagnostic Biomarkers Get ready to chew on this: Roche Diagnostics is bringing something new to Nordic Bioscience's CLIA lab. They're offering up their Endotrophin research prototype assay on the cobas® e801 Analyzer. Now, what does this mean for the scientific world? Well, it might just shake things up for those battling cardiovascular and...

Continue Reading
Phoenix Contact Achieves Guinness Record in Wiring

Updated Category News Views 160

A Blitz of Wires and Innovation Boy, did Phoenix Contact shake things up in Blomberg. On a crisp November day, a group of fresh-faced first-year students pulled off something astounding—wiring 500 terminal blocks in a jaw-dropping 2 minutes and 20 seconds. This wasn’t just any effort; it was enough to earn them a shiny new Guinness World Record. What they did wasn’t...

Continue Reading
DoGo Power Revamps Energy for Remote Indonesian Isle

Updated Category News Views 77

Bringing Light to Pagerungan Kecil Island These days, if you wander into the fishing communities of Pagerungan Kecil Island, the buzz isn't just from the daily catch. Residents are talking about power, and not the kind you get from a generator spluttering along—I'm talking about a brand-new energy storage system that’s turning the lights on in ways these folks have...

Continue Reading
Evotec’s $2.9M Grant Advances Drug Safety Tech

Updated Category News Views 101

Revitalizing Drug Development with Human Stem Cells Evotec's latest win—a crisp $2.9 million grant from the Gates Foundation—is like a shot of adrenaline for drug safety innovation. This isn't just another drop in the bucket; it's a solid boost toward improving how we screen potential drugs for fetal risks before they're tossed into the costly whirlpool of clinical...

Continue Reading
Medtronic's Bold Move to Own Carotid Market Full-Scale

Updated Category News Views 44

When a giant like Medtronic makes a move, you can bet investors take notice, and this latest acquisition is no exception. They’re reaching into their deep pockets to acquire Contego Medical, a company shaking up the world of carotid artery disease treatments. It’s a tactical strike to solidify their leadership in cardiovascular solutions. Medtronic's Bet on Innovation...

Continue Reading
ROBOTERA Debuts XHAND 1 Pro-U in NVIDIA Demo

Updated Category News Views 20

ROBOTERA Steps Up with XHAND 1 Pro-U Move over, traditional robotics; ROBOTERA is here to shake things up with their latest marvel, the XHAND 1 Pro-U. This futuristic gadget isn't just making waves at the Conference on Robot Learning (CoRL) where Jim Fan of NVIDIA spotlighted it in his GR00T 2 demo, it's setting a new bar for robotic dexterity. Hand in Glove with Human...

Continue Reading
Atomera Preps for Key Craig-Hallum Conference

Updated Category News Views 13

Unpacking the NYC Gathering Alight, let's comb through the moving parts here. Atomera Inc., ticker NASDAQ: ATOM for those eyeing the dance of numbers, is all set to step into the limelight at the 17th Annual Craig-Hallum Alpha Select Conference on November 17, 2026. This shindig isn't just another date on the calendar; it's a strategic haunt where Atomera will rub...

Continue Reading
ICCSD in Beijing: AI and Culture's Future Explored

Updated Category News Views 114

AI's Intersection with Culture in the Spotlight Imagine a room full of people hammering out the future of AI and culture—it starts to feel like a melting pot for the mind. That was the scene in Beijing when the ICCSD Advisory Committee congregated on October 26, 2026. With experts pooling from four different countries, there was no shortage of fireworks. They hashed out...

Continue Reading

Top 5 Most Recently Viewed Articles

CSX Corporation Teams Up for Q1 Earnings Conference Call

Updated Category News Views 131

CSX Corporation's Upcoming First Quarter Earnings Release CSX Corporation (NASDAQ: CSX) is excited to announce its first-quarter earnings release slated for a date following the market close. This pivotal moment will take place on a Wednesday, with management inviting participants to join their insightful conference call. Details of the Earnings Call A live webcast and...

Continue Reading
Innovative ReWalk 7 Exoskeleton Now Available for All Users

Updated Category News Views 345

The Launch of ReWalk 7 Personal Exoskeleton Lifeward Ltd., known for its groundbreaking innovations in medical technology, has recently unveiled its seventh generation of personal exoskeletons, the ReWalk 7. This next-generation device is now available throughout the United States, primarily aiming to benefit individuals with spinal cord injuries (SCI). This remarkable...

Continue Reading
Eve's Certification Progress Marks Aviation Milestone

Updated Category News Views 51

Certification: A New Lease on Air Mobility Folks, the air mobility future is taking one giant leap forward, and Eve Air Mobility is right at the helm. With Brazil’s aviation authority spearheading a consultation for updated airworthiness criteria and Eve stepping up for European certification, these advancements aren't just footnotes—they're headlines. NYSE:EVEX has...

Continue Reading
Exciting Launch of Lofthill Residences: A Premier Investment Hub

Updated Category News Views 164

Lofthill Residences: A Fresh Investment Opportunity in Kuala Lumpur The real estate market in Kuala Lumpur has taken an exciting turn with the introduction of Lofthill Residences, a groundbreaking initiative by TRE Towers and the Armani Group. Conveniently located near the vibrant KLCC and just a short walk from the Raja Uda MRT station, this development stands out as a...

Continue Reading
Exclaimer Welcomes Rob Singer as CEO to Propel Growth

Updated Category News Views 385

Exclaimer Welcomes New Leadership for Future Growth Exclaimer, a leader in email signature management, has announced the appointment of Rob Singer as its new CEO. This comes at a key moment for the company, which has recently doubled its annual revenue and is set to expand its presence with new offices opening soon. Experience and Vision Matter Rob Singer comes to...

Continue Reading